References
- Ashley, O. S., Marsden, M. E., & Brady, T. M. (2003). Effectiveness of substance abuse treatment programming for women: A review. The American Journal of Drug and Alcohol Abuse, 29(1), 19–53. https://doi.org/https://doi.org/10.1081/ada-120018838
- Barron, M. L., Flick, L. H., Cook, C. A., Homan, S. M., & Campbell, C. (2008). Associations between psychiatric disorders and menstrual cycle characteristics. Archives of Psychiatric Nursing, 22(5), 254–265. https://doi.org/https://doi.org/10.1016/j.apnu.2007.11.001
- Brecht, M. L., Anglin, M. D., & Dylan, M. (2005). Coerced treatment for methamphetamine abuse: Differential patient characteristics and outcomes. The American Journal of Drug and Alcohol Abuse, 31(2), 337–356. https://doi.org/https://doi.org/10.1081/ADA-56764
- Brecht, M.-L., O'Brien, A., von Mayrhauser, C., & Anglin, M. D. (2004). Methamphetamine use behaviors and gender differences. Addictive Behaviors, 29(1), 89–106. https://doi.org/https://doi.org/10.1016/S0306-4603(03)00082-0
- Cohen, J. B., Dickow, A., Horner, K., Zweben, J. E., Balabis, J., Vandersloot, D., & Reiber, C., Methamphetamine Treatment Project (2003). Abuse and violence history of men and women in treatment for methamphetamine dependence. The American Journal on Addictions, 12(5), 377–385. https://doi.org/https://doi.org/10.1080/10550490390240701
- Grella, C. E. (2008). From generic to gender-responsive treatment: Changes in social policies, treatment services, and outcomes of women in substance abuse treatment. Journal of Psychoactive Drugs, 40 [Suppl. 5:327-43](sup5), 327–343. https://doi.org/https://doi.org/10.1080/02791072.2008.10400661
- Grella, C. E., & Joshi, V. (1999). Gender differences in drug treatment careers among clients in the National Drug Abuse Treatment Outcome Study. The American Journal of Drug and Alcohol Abuse, 25(3), 385–406. https://doi.org/https://doi.org/10.1081/ada-100101868
- Hodgins, D. C., el-Guebaly, N., & Armstrong, S. (1995). Prospective and retrospective reports of mood states before relapse to substance use. Journal of Consulting and Clinical Psychology, 63(3), 400–407. https://doi.org/https://doi.org/10.1037/0022-006X.63.3.400
- Hser, Y. I., Evans, E., & Huang, Y. C. (2005). Treatment outcomes among women and men methamphetamine abusers in California. Journal of Substance Abuse Treatment, 28(1), 77–85. https://doi.org/https://doi.org/10.1016/j.jsat.2004.10.009
- Hser, Y.-I., Huang, Y., Teruya, C., & Anglin, M. D. (2004). Gender differences in treatment outcomes over a three-year period: A path model analysis. Journal of Drug Issues, 34(2), 419–440. https://doi.org/https://doi.org/10.1177/002204260403400208
- Kennedy, A. P., Epstein, D. H., Phillips, K. A., & Preston, K. L. (2013). Sex differences in cocaine/heroin users: Drug-use triggers and craving in daily life. Drug and Alcohol Dependence, 132(1/2), 29–37. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2012.12.025
- Larimer, M. E., Palmer, R. S., & Marlatt, G. A. (1999). Relapse prevention. An overview of Marlatt’s cognitive-behavioral model. Alcohol Research and Health, 23(2), 151–160.
- McKay, J. R., Rutherford, M. J., Cacciola, J. S., Kabasakalian-McKay, R., & Alterman, A. I. (1996). Gender differences in the relapse experiences of cocaine patients. The Journal of Nervous and Mental Disease, 184(10), 616–622. https://doi.org/https://doi.org/10.1097/00005053-199610000-00006
- O’Doherty, F., & Davies, J. B. (1987). Life events and addiction: A critical review. British Journal of Addiction, 82(2), 127–137. https://doi.org/https://doi.org/10.1111/j.1360-0443.1987.tb01451.x
- Obert, J. L., McCann, M. J., Marinelli-Casey, P., Weiner, A., Minsky, S., Brethen, P., & Rawson, R. (2000). The matrix model of outpatient stimulant abuse treatment: History and description. Journal of Psychoactive Drugs, 32(2), 157–164. https://doi.org/https://doi.org/10.1080/02791072.2000.10400224
- Rawson, R. A., Huber, A., Brethen, P., Obert, J., Gulati, V., Shoptaw, S., & Ling, W. (2002). Status of methamphetamine users 2-5 years after outpatient treatment. Journal of Addictive Diseases, 21(1), 107–119. https://doi.org/https://doi.org/10.1300/j069v21n01_09
- Rawson, R. A., Marinelli-Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., McCann, M. J., Obert, J., Pennell, S., Reiber, C., Vandersloot, D., & Zweben, J., Methamphetamine Treatment Project Corporate Authors. (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction (Abingdon, England), 99(6), 708–717. https://doi.org/https://doi.org/10.1111/j.1360-0443.2004.00707.x
- Shimane, T., Imamura, K., Ikeda, K., Yamamoto, M., Tsuji, M., Nagayo, M., & Matsumoto, T. (2015). Examination of the reliability and validity of the Japanese version of DAST-20. Japanese Journal of Alcohol Studies and Drug Dependence, 50(6), 310–324.
- Shimane, T., Sugawara, M., Okazaki, S., Izumino, R., (2013). Addiction Consultation Team, consultant section. Metropolitan Chubu Mental Health Welfare Center., & Workbook, O. (3rd ed.). Edited and published by Tokyo Metropolitan Chubu Mental Health Welfare Center, Department of Public Relations Support, Consultation Section, pp. 24, 34.
- Skinner, H. A., & Goldberg, A. E. (1986). Evidence for a drug dependence syndrome among narcotic users. British Journal of Addiction, 81(4), 479–484. https://doi.org/https://doi.org/10.1111/j.1360-0443.1986.tb00359.x
- Sun, A. P. (2007). Relapse among substance-abusing women: Components and processes. Substance Use & Misuse, 42(1), 1–21. https://doi.org/https://doi.org/10.1080/10826080601094082
- Takahashi, S., Ohno, H., Someya, T., Kanba, S., Ozaki, N., & Mimura, S, (T. Murai & Supervised by Japanese Society of Psychiatry and Neurology (Translators)) (2014). DSM-5 manual for diagnosis and statistics of mental illness. American Psychiatric Association (APA). Igaku-Shoin. pp. 171–174.
- Trotter, R. T., Bowen, A. M., Baldwin, J. A., & Price, L. J. (1996). The efficacy of network-based HIV/AIDS risk reduction programs in midsized towns in the United States. Journal of Drug Issues, 26(3), 591–605. https://doi.org/https://doi.org/10.1177/002204269602600305
- Vearrier, D., Greenberg, M. I., Miller, S. N., Okaneku, J. T., & Haggerty, D. A. (2012). Methamphetamine: History, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Disease-a-Month: Dm, 58(2), 38–89. https://doi.org/https://doi.org/10.1016/j.disamonth.2011.09.004
- Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., & Iguchi, M., Methamphetamine Treatment Project. (2004). Psychiatric symptoms in methamphetamine users. The American Journal on Addictions, 13(2), 181–190. https://doi.org/https://doi.org/10.1080/10550490490436055